What is the Risk?
At Risk PopulationsUntil an emerging disease is detected and characterized, health officials will not know the segment of the population that will be most at risk. Early detection and robust epidemiological investigations are needed to determine who will be most impacted by the particular disease or biological agent.
The Potential for Communities to be TargetedRegardless of the origin, new disease outbreaks often lead to communities being unjustly singled out by others as “responsible” for the disease. These assumptions are based on perceived associations like a virus’ country of origin or the community in which it was first identified. Clear and consistent risk communication is essential to dispel myths before they take hold.
Biological releases in New York City could be devastating to plants and animals. Microorganisms and pathogens affect their hosts in different ways and severity of the threat depends upon the type of biological material released.
A significant biological release has the potential to cause the same type of wide-ranging impacts that would result from a significant chemical release.
A New Threat from Synthetic BiologyThis hazard includes the growing threat theorized from recent advances in synthetic biology. The creation and manipulation of pathogens is facilitated by increasingly accessible technologies and starting materials, including DNA sequences in public databases. A wide range of pathogen characteristics could be explored as part of such efforts. With regard to pathogens, synthetic biology is expected to:
- Expand the range of what could be produced, including making bacteria and viruses more harmful;
- Decrease the amount of time required to engineer such organisms; and
- Expand the range of actors who could undertake such efforts.
- Re-creating known pathogenic viruses. Constructing a known, naturally occurring pathogenic virus from the starting point of information about its genetic sequence.
- Making existing bacteria more dangerous. Creating a modified version of a known bacterium in which one or more traits have been altered to make the bacterium more dangerous.
- Making biochemicals via in situ synthesis. Engineering an organism, such as a microorganism that can survive in the human gut, to produce a desired biochemical and delivering this microorganism in such a way that it can produce and release this product in situ.
A Decrease in Global Surveillance EffortsAn emerging disease can arise anywhere in the world. Emerging diseases are monitored globally by the World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), and other national and international public health organizations for their potential to develop into a pandemic. Global disease surveillance and robust field investigations are needed for early detection of a global disease outbreak before it reaches our shores. Recent budget cuts to the CDC’s global health security initiatives have significantly decreased the City’s ability to know beforehand about an emerging infectious disease and prepare mitigation efforts that could decrease the impact to the City.